Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
A prospective study of three different doses of Degarelix in late luteal phase of women undergoing ovarian stimulation for IVF
Epistemonikos ID: 1765bf4df737c6da7ca5ddb65e64ed8de6d7607e
First added on: May 21, 2024